Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 19

Page
per page
  1. Lestaurtinib
    A4513 Lestaurtinib
     1 Citation
    Summary: JAK2/FLT3/TrkA inhibitor
      Soluble in DMSO
  2. Linifanib (ABT-869)
    A2949 Linifanib (ABT-869)
    Target: VEGFR|PDGFR
    Summary: VEGFR/PDGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
  3. Cabozantinib (XL184, BMS-907351)
    A2977 Cabozantinib (XL184, BMS-907351)
    Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
      ≥25.08 mg/mL
  4. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  5. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  6. TCS 359
    A2323 TCS 359
    Summary: Potent FLT3 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥9 mg/mL
  7. Tandutinib (MLN518)
    B1526 Tandutinib (MLN518)
    Summary: FLT3 inhibitor,potent and selective
      ≥17.85 mg/mL
  8. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  9. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  10. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL

Items 1-10 of 19

Page
per page